Persistent physical symptoms after COVID-19 infection and the risk of Somatic Symptom Disorder
Evidence shows that many patients with COVID-19 present persistent symptoms after the acute infection. Some patients may be at a high risk of developing Somatic Symptom Disorder (SSD), in which persistent symptoms are accompanied by excessive and disproportionate health-related thoughts, feelings an...
Gespeichert in:
| Veröffentlicht in: | Journal of psychosomatic research 2023-03, Vol.166, p.111172-111172, Article 111172 |
|---|---|
| Hauptverfasser: | , , , , , , , , , , , , , |
| Format: | Artikel |
| Sprache: | eng |
| Schlagworte: | |
| Online-Zugang: | Volltext |
| Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
| container_end_page | 111172 |
|---|---|
| container_issue | |
| container_start_page | 111172 |
| container_title | Journal of psychosomatic research |
| container_volume | 166 |
| creator | Horn, Mathilde Wathelet, Marielle Amad, Ali Martignène, Niels Lathiere, Thomas Khelfaoui, Kamélia Rousselle, Margot El Qaoubii, Oumaïma Vuotto, Fanny Faure, Karine Creupelandt, Coralie Vaiva, Guillaume Fovet, Thomas D'Hondt, Fabien |
| description | Evidence shows that many patients with COVID-19 present persistent symptoms after the acute infection. Some patients may be at a high risk of developing Somatic Symptom Disorder (SSD), in which persistent symptoms are accompanied by excessive and disproportionate health-related thoughts, feelings and behaviors regarding these symptoms. This study assessed the frequency of persistent physical symptoms and SSD and their associated factors in patients with confirmed COVID-19.
We conducted a longitudinal retrospective study after the first two French lockdowns at the Lille University Hospital (France), including all patients with confirmed COVID-19. Persistent physical symptoms and excessive preoccupations for these symptoms were measured 8 to 10 months after the onset of COVID-19. The combination of the Patient Health Questionnaire-15 and the Somatic Symptom Disorder-B Criteria Scale was used to identify the individuals likely to present with SSD. Two linear regression models were performed to identify sociodemographic and medical risk factors of SSD.
Among the 377 patients with a laboratory-confirmed diagnosis, 220 (58.4%) completed the questionnaires. Sixty-five percent of the 220 included patients required hospitalization, 53.6% presented at least one persistent physical symptom and 10.4% were considered to present SSD. Female sex, older age, infection during the second wave and having probable PTSD were significantly associated with the severity of SSD and SSD was associated with a significantly higher healthcare use.
The identification of SSD should encourage clinicians to move beyond the artificial somatic/psychiatric dualism and contribute to a better alliance based on multi-disciplinary care.
•Many patients with COVID-19 present with persistent symptoms after the acute phase.•10.4% of these patients were considered at risk of Somatic Symptom Disorder (SSD).•Age, sex, and psychotraumatic symptoms were associated with the severity of SSD.•Identification of SSD should incite clinicians to surpass the somatic/psychiatric dualism. |
| doi_str_mv | 10.1016/j.jpsychores.2023.111172 |
| format | Article |
| fullrecord | <record><control><sourceid>proquest_pubme</sourceid><recordid>TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_9876030</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><els_id>S0022399923000272</els_id><sourcerecordid>2773125986</sourcerecordid><originalsourceid>FETCH-LOGICAL-c513t-299e16de1e844c5e85b60909324bfe51b648f7cb671d1bbc7135bf9baebe1ab33</originalsourceid><addsrcrecordid>eNqFkU9v1DAQxS0EokvhKyAf4ZDFYydOfEEqW6CVVipSgSOW7UyIlyRO7exK--3JKqX8ueDLSJ733mjmRwgFtgYG8s1uvRvT0bUhYlpzxsUa5lfyR2QFVakyEJI9JivGOM-EUuqMPEtpxxiTihdPyZmQpZCgYEW-fcKYfJpwmOjYHpN3pqPp2I9T6BM1zYSRbm6-Xl9moKgfGnSTDwM1Q02nFmn06QcNDb0NvZm8o7eLk176FGKN8Tl50pgu4Yv7ek6-fHj_eXOVbW8-Xm8utpkrQEwZVwpB1ghY5bkrsCqsZIopwXPbYAFW5lVTOitLqMFaV4IobKOsQYtgrBDn5O2SO-5tj7Wb14mm02P0vYlHHYzXf3cG3-rv4aBVVUom2Bzweglo_7FdXWz16Y_lFVdCqgPM2lf3w2K422OadO-Tw64zA4Z90rwsBfBCVXKWVovUxZBSxOYhG5g-odQ7_RulPqHUC8rZ-vLPlR6Mv9jNgneLAOfDHjxGnZzHwWHt44xJ18H_f8pPi9e2cQ</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>2773125986</pqid></control><display><type>article</type><title>Persistent physical symptoms after COVID-19 infection and the risk of Somatic Symptom Disorder</title><source>MEDLINE</source><source>Elsevier ScienceDirect Journals</source><creator>Horn, Mathilde ; Wathelet, Marielle ; Amad, Ali ; Martignène, Niels ; Lathiere, Thomas ; Khelfaoui, Kamélia ; Rousselle, Margot ; El Qaoubii, Oumaïma ; Vuotto, Fanny ; Faure, Karine ; Creupelandt, Coralie ; Vaiva, Guillaume ; Fovet, Thomas ; D'Hondt, Fabien</creator><creatorcontrib>Horn, Mathilde ; Wathelet, Marielle ; Amad, Ali ; Martignène, Niels ; Lathiere, Thomas ; Khelfaoui, Kamélia ; Rousselle, Margot ; El Qaoubii, Oumaïma ; Vuotto, Fanny ; Faure, Karine ; Creupelandt, Coralie ; Vaiva, Guillaume ; Fovet, Thomas ; D'Hondt, Fabien</creatorcontrib><description>Evidence shows that many patients with COVID-19 present persistent symptoms after the acute infection. Some patients may be at a high risk of developing Somatic Symptom Disorder (SSD), in which persistent symptoms are accompanied by excessive and disproportionate health-related thoughts, feelings and behaviors regarding these symptoms. This study assessed the frequency of persistent physical symptoms and SSD and their associated factors in patients with confirmed COVID-19.
We conducted a longitudinal retrospective study after the first two French lockdowns at the Lille University Hospital (France), including all patients with confirmed COVID-19. Persistent physical symptoms and excessive preoccupations for these symptoms were measured 8 to 10 months after the onset of COVID-19. The combination of the Patient Health Questionnaire-15 and the Somatic Symptom Disorder-B Criteria Scale was used to identify the individuals likely to present with SSD. Two linear regression models were performed to identify sociodemographic and medical risk factors of SSD.
Among the 377 patients with a laboratory-confirmed diagnosis, 220 (58.4%) completed the questionnaires. Sixty-five percent of the 220 included patients required hospitalization, 53.6% presented at least one persistent physical symptom and 10.4% were considered to present SSD. Female sex, older age, infection during the second wave and having probable PTSD were significantly associated with the severity of SSD and SSD was associated with a significantly higher healthcare use.
The identification of SSD should encourage clinicians to move beyond the artificial somatic/psychiatric dualism and contribute to a better alliance based on multi-disciplinary care.
•Many patients with COVID-19 present with persistent symptoms after the acute phase.•10.4% of these patients were considered at risk of Somatic Symptom Disorder (SSD).•Age, sex, and psychotraumatic symptoms were associated with the severity of SSD.•Identification of SSD should incite clinicians to surpass the somatic/psychiatric dualism.</description><identifier>ISSN: 0022-3999</identifier><identifier>EISSN: 1879-1360</identifier><identifier>DOI: 10.1016/j.jpsychores.2023.111172</identifier><identifier>PMID: 36736191</identifier><language>eng</language><publisher>England: Elsevier Inc</publisher><subject>Communicable Disease Control ; COVID-19 ; Female ; Humans ; Life Sciences ; Long COVID, post-acute sequelae of COVID-19 ; Medically Unexplained Symptoms ; Post-COVID condition ; Post-traumatic stress disorder ; Retrospective Studies ; Somatic Symptom Disorder ; Somatoform Disorders - diagnosis ; Somatoform Disorders - epidemiology ; Somatoform Disorders - etiology</subject><ispartof>Journal of psychosomatic research, 2023-03, Vol.166, p.111172-111172, Article 111172</ispartof><rights>2023 Elsevier Inc.</rights><rights>Copyright © 2023 Elsevier Inc. All rights reserved.</rights><rights>Distributed under a Creative Commons Attribution 4.0 International License</rights><rights>2023 Published by Elsevier Inc. 2023</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c513t-299e16de1e844c5e85b60909324bfe51b648f7cb671d1bbc7135bf9baebe1ab33</citedby><cites>FETCH-LOGICAL-c513t-299e16de1e844c5e85b60909324bfe51b648f7cb671d1bbc7135bf9baebe1ab33</cites><orcidid>0000-0003-0077-624X ; 0000-0001-5683-0490</orcidid></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://dx.doi.org/10.1016/j.jpsychores.2023.111172$$EHTML$$P50$$Gelsevier$$H</linktohtml><link.rule.ids>230,314,777,781,882,3537,27905,27906,45976</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/36736191$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink><backlink>$$Uhttps://hal.univ-lille.fr/hal-04829369$$DView record in HAL$$Hfree_for_read</backlink></links><search><creatorcontrib>Horn, Mathilde</creatorcontrib><creatorcontrib>Wathelet, Marielle</creatorcontrib><creatorcontrib>Amad, Ali</creatorcontrib><creatorcontrib>Martignène, Niels</creatorcontrib><creatorcontrib>Lathiere, Thomas</creatorcontrib><creatorcontrib>Khelfaoui, Kamélia</creatorcontrib><creatorcontrib>Rousselle, Margot</creatorcontrib><creatorcontrib>El Qaoubii, Oumaïma</creatorcontrib><creatorcontrib>Vuotto, Fanny</creatorcontrib><creatorcontrib>Faure, Karine</creatorcontrib><creatorcontrib>Creupelandt, Coralie</creatorcontrib><creatorcontrib>Vaiva, Guillaume</creatorcontrib><creatorcontrib>Fovet, Thomas</creatorcontrib><creatorcontrib>D'Hondt, Fabien</creatorcontrib><title>Persistent physical symptoms after COVID-19 infection and the risk of Somatic Symptom Disorder</title><title>Journal of psychosomatic research</title><addtitle>J Psychosom Res</addtitle><description>Evidence shows that many patients with COVID-19 present persistent symptoms after the acute infection. Some patients may be at a high risk of developing Somatic Symptom Disorder (SSD), in which persistent symptoms are accompanied by excessive and disproportionate health-related thoughts, feelings and behaviors regarding these symptoms. This study assessed the frequency of persistent physical symptoms and SSD and their associated factors in patients with confirmed COVID-19.
We conducted a longitudinal retrospective study after the first two French lockdowns at the Lille University Hospital (France), including all patients with confirmed COVID-19. Persistent physical symptoms and excessive preoccupations for these symptoms were measured 8 to 10 months after the onset of COVID-19. The combination of the Patient Health Questionnaire-15 and the Somatic Symptom Disorder-B Criteria Scale was used to identify the individuals likely to present with SSD. Two linear regression models were performed to identify sociodemographic and medical risk factors of SSD.
Among the 377 patients with a laboratory-confirmed diagnosis, 220 (58.4%) completed the questionnaires. Sixty-five percent of the 220 included patients required hospitalization, 53.6% presented at least one persistent physical symptom and 10.4% were considered to present SSD. Female sex, older age, infection during the second wave and having probable PTSD were significantly associated with the severity of SSD and SSD was associated with a significantly higher healthcare use.
The identification of SSD should encourage clinicians to move beyond the artificial somatic/psychiatric dualism and contribute to a better alliance based on multi-disciplinary care.
•Many patients with COVID-19 present with persistent symptoms after the acute phase.•10.4% of these patients were considered at risk of Somatic Symptom Disorder (SSD).•Age, sex, and psychotraumatic symptoms were associated with the severity of SSD.•Identification of SSD should incite clinicians to surpass the somatic/psychiatric dualism.</description><subject>Communicable Disease Control</subject><subject>COVID-19</subject><subject>Female</subject><subject>Humans</subject><subject>Life Sciences</subject><subject>Long COVID, post-acute sequelae of COVID-19</subject><subject>Medically Unexplained Symptoms</subject><subject>Post-COVID condition</subject><subject>Post-traumatic stress disorder</subject><subject>Retrospective Studies</subject><subject>Somatic Symptom Disorder</subject><subject>Somatoform Disorders - diagnosis</subject><subject>Somatoform Disorders - epidemiology</subject><subject>Somatoform Disorders - etiology</subject><issn>0022-3999</issn><issn>1879-1360</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2023</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNqFkU9v1DAQxS0EokvhKyAf4ZDFYydOfEEqW6CVVipSgSOW7UyIlyRO7exK--3JKqX8ueDLSJ733mjmRwgFtgYG8s1uvRvT0bUhYlpzxsUa5lfyR2QFVakyEJI9JivGOM-EUuqMPEtpxxiTihdPyZmQpZCgYEW-fcKYfJpwmOjYHpN3pqPp2I9T6BM1zYSRbm6-Xl9moKgfGnSTDwM1Q02nFmn06QcNDb0NvZm8o7eLk176FGKN8Tl50pgu4Yv7ek6-fHj_eXOVbW8-Xm8utpkrQEwZVwpB1ghY5bkrsCqsZIopwXPbYAFW5lVTOitLqMFaV4IobKOsQYtgrBDn5O2SO-5tj7Wb14mm02P0vYlHHYzXf3cG3-rv4aBVVUom2Bzweglo_7FdXWz16Y_lFVdCqgPM2lf3w2K422OadO-Tw64zA4Z90rwsBfBCVXKWVovUxZBSxOYhG5g-odQ7_RulPqHUC8rZ-vLPlR6Mv9jNgneLAOfDHjxGnZzHwWHt44xJ18H_f8pPi9e2cQ</recordid><startdate>20230301</startdate><enddate>20230301</enddate><creator>Horn, Mathilde</creator><creator>Wathelet, Marielle</creator><creator>Amad, Ali</creator><creator>Martignène, Niels</creator><creator>Lathiere, Thomas</creator><creator>Khelfaoui, Kamélia</creator><creator>Rousselle, Margot</creator><creator>El Qaoubii, Oumaïma</creator><creator>Vuotto, Fanny</creator><creator>Faure, Karine</creator><creator>Creupelandt, Coralie</creator><creator>Vaiva, Guillaume</creator><creator>Fovet, Thomas</creator><creator>D'Hondt, Fabien</creator><general>Elsevier Inc</general><general>Elsevier</general><general>Published by Elsevier Inc</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope><scope>1XC</scope><scope>5PM</scope><orcidid>https://orcid.org/0000-0003-0077-624X</orcidid><orcidid>https://orcid.org/0000-0001-5683-0490</orcidid></search><sort><creationdate>20230301</creationdate><title>Persistent physical symptoms after COVID-19 infection and the risk of Somatic Symptom Disorder</title><author>Horn, Mathilde ; Wathelet, Marielle ; Amad, Ali ; Martignène, Niels ; Lathiere, Thomas ; Khelfaoui, Kamélia ; Rousselle, Margot ; El Qaoubii, Oumaïma ; Vuotto, Fanny ; Faure, Karine ; Creupelandt, Coralie ; Vaiva, Guillaume ; Fovet, Thomas ; D'Hondt, Fabien</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c513t-299e16de1e844c5e85b60909324bfe51b648f7cb671d1bbc7135bf9baebe1ab33</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2023</creationdate><topic>Communicable Disease Control</topic><topic>COVID-19</topic><topic>Female</topic><topic>Humans</topic><topic>Life Sciences</topic><topic>Long COVID, post-acute sequelae of COVID-19</topic><topic>Medically Unexplained Symptoms</topic><topic>Post-COVID condition</topic><topic>Post-traumatic stress disorder</topic><topic>Retrospective Studies</topic><topic>Somatic Symptom Disorder</topic><topic>Somatoform Disorders - diagnosis</topic><topic>Somatoform Disorders - epidemiology</topic><topic>Somatoform Disorders - etiology</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Horn, Mathilde</creatorcontrib><creatorcontrib>Wathelet, Marielle</creatorcontrib><creatorcontrib>Amad, Ali</creatorcontrib><creatorcontrib>Martignène, Niels</creatorcontrib><creatorcontrib>Lathiere, Thomas</creatorcontrib><creatorcontrib>Khelfaoui, Kamélia</creatorcontrib><creatorcontrib>Rousselle, Margot</creatorcontrib><creatorcontrib>El Qaoubii, Oumaïma</creatorcontrib><creatorcontrib>Vuotto, Fanny</creatorcontrib><creatorcontrib>Faure, Karine</creatorcontrib><creatorcontrib>Creupelandt, Coralie</creatorcontrib><creatorcontrib>Vaiva, Guillaume</creatorcontrib><creatorcontrib>Fovet, Thomas</creatorcontrib><creatorcontrib>D'Hondt, Fabien</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><collection>Hyper Article en Ligne (HAL)</collection><collection>PubMed Central (Full Participant titles)</collection><jtitle>Journal of psychosomatic research</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Horn, Mathilde</au><au>Wathelet, Marielle</au><au>Amad, Ali</au><au>Martignène, Niels</au><au>Lathiere, Thomas</au><au>Khelfaoui, Kamélia</au><au>Rousselle, Margot</au><au>El Qaoubii, Oumaïma</au><au>Vuotto, Fanny</au><au>Faure, Karine</au><au>Creupelandt, Coralie</au><au>Vaiva, Guillaume</au><au>Fovet, Thomas</au><au>D'Hondt, Fabien</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Persistent physical symptoms after COVID-19 infection and the risk of Somatic Symptom Disorder</atitle><jtitle>Journal of psychosomatic research</jtitle><addtitle>J Psychosom Res</addtitle><date>2023-03-01</date><risdate>2023</risdate><volume>166</volume><spage>111172</spage><epage>111172</epage><pages>111172-111172</pages><artnum>111172</artnum><issn>0022-3999</issn><eissn>1879-1360</eissn><abstract>Evidence shows that many patients with COVID-19 present persistent symptoms after the acute infection. Some patients may be at a high risk of developing Somatic Symptom Disorder (SSD), in which persistent symptoms are accompanied by excessive and disproportionate health-related thoughts, feelings and behaviors regarding these symptoms. This study assessed the frequency of persistent physical symptoms and SSD and their associated factors in patients with confirmed COVID-19.
We conducted a longitudinal retrospective study after the first two French lockdowns at the Lille University Hospital (France), including all patients with confirmed COVID-19. Persistent physical symptoms and excessive preoccupations for these symptoms were measured 8 to 10 months after the onset of COVID-19. The combination of the Patient Health Questionnaire-15 and the Somatic Symptom Disorder-B Criteria Scale was used to identify the individuals likely to present with SSD. Two linear regression models were performed to identify sociodemographic and medical risk factors of SSD.
Among the 377 patients with a laboratory-confirmed diagnosis, 220 (58.4%) completed the questionnaires. Sixty-five percent of the 220 included patients required hospitalization, 53.6% presented at least one persistent physical symptom and 10.4% were considered to present SSD. Female sex, older age, infection during the second wave and having probable PTSD were significantly associated with the severity of SSD and SSD was associated with a significantly higher healthcare use.
The identification of SSD should encourage clinicians to move beyond the artificial somatic/psychiatric dualism and contribute to a better alliance based on multi-disciplinary care.
•Many patients with COVID-19 present with persistent symptoms after the acute phase.•10.4% of these patients were considered at risk of Somatic Symptom Disorder (SSD).•Age, sex, and psychotraumatic symptoms were associated with the severity of SSD.•Identification of SSD should incite clinicians to surpass the somatic/psychiatric dualism.</abstract><cop>England</cop><pub>Elsevier Inc</pub><pmid>36736191</pmid><doi>10.1016/j.jpsychores.2023.111172</doi><tpages>1</tpages><orcidid>https://orcid.org/0000-0003-0077-624X</orcidid><orcidid>https://orcid.org/0000-0001-5683-0490</orcidid><oa>free_for_read</oa></addata></record> |
| fulltext | fulltext |
| identifier | ISSN: 0022-3999 |
| ispartof | Journal of psychosomatic research, 2023-03, Vol.166, p.111172-111172, Article 111172 |
| issn | 0022-3999 1879-1360 |
| language | eng |
| recordid | cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_9876030 |
| source | MEDLINE; Elsevier ScienceDirect Journals |
| subjects | Communicable Disease Control COVID-19 Female Humans Life Sciences Long COVID, post-acute sequelae of COVID-19 Medically Unexplained Symptoms Post-COVID condition Post-traumatic stress disorder Retrospective Studies Somatic Symptom Disorder Somatoform Disorders - diagnosis Somatoform Disorders - epidemiology Somatoform Disorders - etiology |
| title | Persistent physical symptoms after COVID-19 infection and the risk of Somatic Symptom Disorder |
| url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-19T00%3A32%3A11IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_pubme&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Persistent%20physical%20symptoms%20after%20COVID-19%20infection%20and%20the%20risk%20of%20Somatic%20Symptom%20Disorder&rft.jtitle=Journal%20of%20psychosomatic%20research&rft.au=Horn,%20Mathilde&rft.date=2023-03-01&rft.volume=166&rft.spage=111172&rft.epage=111172&rft.pages=111172-111172&rft.artnum=111172&rft.issn=0022-3999&rft.eissn=1879-1360&rft_id=info:doi/10.1016/j.jpsychores.2023.111172&rft_dat=%3Cproquest_pubme%3E2773125986%3C/proquest_pubme%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=2773125986&rft_id=info:pmid/36736191&rft_els_id=S0022399923000272&rfr_iscdi=true |